Bendeka Injection, Solution
Product Images NDC 63459-348

This is a description of a drug called BENDEKA (bendamustine HCI) Injection used as a cytotoxic agent. It is stored in the refrigerator and should be used with caution during handling and preparation to avoid exposure. Gloves and safety glasses are recommended. The drug is a sterile multi-dose vial and must be diluted prior to administration. The package insert should be consulted for dosing and dilution information. The drug contains bendamustine hydrochloride, USP, propylene glycol, monothioglycerol, NF in polyethylene glycol 400, NF, and sodium hydroxide, NF to adjust pH of polyethylene glycol 400. It is distributed by Teva Pharmaceuticals USA, Inc. and is a product of India.*

This is a medication called Bendeka, containing bendamustine HCI, an injection for intravenous infusion only that must be diluted prior to administration. It is a cytotoxic agent, and precautions like using gloves and safety glasses are recommended to avoid exposure during handling and preparation. The usual dosage can be found in the package insert, and it is distributed by Teva Pharmaceuticals USA, Inc. It must be stored in the refrigerator and protected from light.*

This is a description of BENDEKA's injection solution for intravenous infusion. It is distributed by Teva Pharmaceuticals USA, Inc. The injection has a concentration of 25 mg/mL and must be diluted before administration. A table in the package insert provides information on dosing and dilution. The recommended storage temperature is 2° to 8°C, and the solution should be protected from light. The injection should be withdrawn aseptically and transferred into a 50 mL infusion bag, and must not be used if solid or particulate matter is observed.*